Mirapex (pramipexole) is an antidyskinetic (dopamine agonist) used to treat Parkinson’s disease. Mirapex was approved by the FDA in 1997 and is manufactured and distributed by Boehringer Ingelheim and Pfizer. The drug works by imitating the actions of dopamine in the brain that help control muscle tremors associated with Parkinson’s disease.
Mirapex is also used to treat fibromyalgia (chronic muscle pain and fatigue), depression, sleep disorder and restless-leg syndrome.
Mirapex Linked to Compulsive Behavior
A serious concern about Mirapex is the relationship between the drug and a number of compulsive behaviors. In 2005, researchers at the Mayo Clinic a found a direct link to drugs used to treat Parkinson’s disease and compulsive gambling, eating, drinking and sexual activity. This is attributed to the fact that Mirapex and other Parkinson’s drugs are dopamine agonists and imitate the role of dopamine in the brain. Dopamine is directly associated to the pleasure and reward areas of the brain.
Reports have shown that patients taking Mirapex to have gained significant weight after overeating, engaged in extramarital affairs and lost extensive amounts of money by engaging in compulsive gambling and shopping. Studies showed that when use of the drug was discontinued or lessened, the compulsive and, in some cases, hazardous behavior ceased.
To learn more about legal claims relating to Mirapex, consult an attorney who practices in the area of drugs and medical devices.